279 related articles for article (PubMed ID: 8896065)
21. [Serum levels of carboxyterminal propeptide of type I procollagen (PICP), cross-linked carboxyterminal telopeptide region of type I collagen (ICTP) and carboxyterminal parathyroid hormone-related protein (C-PTHrP) in hematological malignancies with bone lesions and hypercalcemia].
Tanaka K; Shiraishi K; Sakamoto A; Jojima H; Masuchi K; Okubo Y; Tanaka M; Fuzimatsu Y; Fukahori S; Osabe S; Imamura Y; Honda J; Oizumi K
Rinsho Ketsueki; 1998 Apr; 39(4):273-80. PubMed ID: 9597894
[TBL] [Abstract][Full Text] [Related]
22. [Hypercalcemia in malignancy].
Eto S
Rinsho Byori; 1994 Sep; 42(9):943-51. PubMed ID: 7967119
[TBL] [Abstract][Full Text] [Related]
23. Acute lymphocytic leukemia in adolescence with multiple osteolytic lesions and hypercalcemia mediated by lymphoblast-producing parathyroid hormone-related peptide: a case report and review of the literature.
Shimonodan H; Nagayama J; Nagatoshi Y; Hatanaka M; Takada A; Iguchi H; Oda Y; Okamura J
Pediatr Blood Cancer; 2005 Sep; 45(3):333-9. PubMed ID: 15700250
[TBL] [Abstract][Full Text] [Related]
24. [Use of diphosphonates in the treatment of hypercalcemia in multiple myeloma: efficacy of 4-amino-hydroxybutylidene-1,1-bisphosphonate (AHButBP)].
Attardo-Parrinello G; Crema F; Merlini G; Spaghi A; Fiorentini ML
Medicina (Firenze); 1988; 8(1):75-6. PubMed ID: 3226251
[No Abstract] [Full Text] [Related]
25. Hypercalcemia of malignancy in the palliative care patient: a treatment strategy.
Kovacs CS; MacDonald SM; Chik CL; Bruera E
J Pain Symptom Manage; 1995 Apr; 10(3):224-32. PubMed ID: 7543127
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical detection of parathyroid hormone-related protein in a squamous cell carcinoma arising from mature cystic teratoma causing humoral hypercalcemia of malignancy.
Takeuchi K; Murata K; Funaki K; Kitazawa S; Kitazawa R
Gynecol Oncol; 2000 Dec; 79(3):504-7. PubMed ID: 11104629
[TBL] [Abstract][Full Text] [Related]
27. Reversible renal insufficiency in multiple myeloma.
Bernstein SP; Humes HD
Arch Intern Med; 1982 Nov; 142(12):2083-6. PubMed ID: 7138157
[TBL] [Abstract][Full Text] [Related]
28. Serum parathyroid hormone-related peptide is associated with systemic inflammation and adverse prognosis in gastroesophageal carcinoma.
Deans C; Wigmore S; Paterson-Brown S; Black J; Ross J; Fearon KC
Cancer; 2005 May; 103(9):1810-8. PubMed ID: 15800880
[TBL] [Abstract][Full Text] [Related]
29. Hypercalcemia due to sun exposure in a patient with multiple myeloma and elevated parathyroid hormone-related protein.
Papapetrou PD; Bergi-Stamatelou M; Karga H; Thanou S
Eur J Endocrinol; 2003 Mar; 148(3):351-5. PubMed ID: 12611617
[TBL] [Abstract][Full Text] [Related]
30. Significance of parathyroid hormone-related protein as a factor stimulating bone resorption and causing hypercalcemia in myeloma.
Tsujimura H; Nagamura F; Iseki T; Kanazawa S; Saisho H
Am J Hematol; 1998 Oct; 59(2):168-70. PubMed ID: 9766803
[TBL] [Abstract][Full Text] [Related]
31. Maxilla osseus sequestre and oral exposure: effects of the treatment of multiple myeloma with bisphosphonates.
Lobato JV; Rodrigues JM; Cavaleiro MV; Lobato JM; Xavier L; Santos JD; Maurício AC
Acta Med Port; 2007; 20(2):185-92. PubMed ID: 17868526
[TBL] [Abstract][Full Text] [Related]
32. Hypercalcemic complication in patients with oral squamous cell carcinoma.
Iwase M; Takemi T; Manabe M; Nagumo M
Int J Oral Maxillofac Surg; 2003 Apr; 32(2):174-80. PubMed ID: 12729778
[TBL] [Abstract][Full Text] [Related]
33. Cancer-induced hypercalcemia.
Lumachi F; Brunello A; Roma A; Basso U
Anticancer Res; 2009 May; 29(5):1551-5. PubMed ID: 19443365
[TBL] [Abstract][Full Text] [Related]
34. Hypercalcemia may indicate Richter's syndrome: report of four cases and review.
Beaudreuil J; Lortholary O; Martin A; Feuillard J; Guillevin L; Lortholary P; Raphael M; Casassus P
Cancer; 1997 Mar; 79(6):1211-5. PubMed ID: 9070500
[TBL] [Abstract][Full Text] [Related]
35. Calcium metabolism in multiple myeloma.
Vigo PL; Corghi E; Mozzana R; Girardello R; Soldati L; Saviano S; Polli EE; Milhaud G
Biomed Pharmacother; 1982; 36(5):240-5. PubMed ID: 7168801
[TBL] [Abstract][Full Text] [Related]
36. Parathyroid hormone-related protein measured at the time of first visit is an indicator of bone metastases and survival in lung carcinoma patients with hypercalcemia.
Hiraki A; Ueoka H; Bessho A; Segawa Y; Takigawa N; Kiura K; Eguchi K; Yoneda T; Tanimoto M; Harada M
Cancer; 2002 Oct; 95(8):1706-13. PubMed ID: 12365018
[TBL] [Abstract][Full Text] [Related]
37. [Hypercalcemia in multiple myeloma].
Takahashi T
Nihon Rinsho; 1995 Mar; 53(3):710-4. PubMed ID: 7699910
[TBL] [Abstract][Full Text] [Related]
38. Ibandronate for the treatment of hypercalcemia or nephrocalcinosis in patients with multiple myeloma and acute renal failure: Case reports.
Henrich D; Hoffmann M; Uppenkamp M; Bergner R
Acta Haematol; 2006; 116(3):165-72. PubMed ID: 17016034
[TBL] [Abstract][Full Text] [Related]
39. Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease.
Kyrtsonis MC; Vassilakopoulos TP; Siakantaris MP; Kokoris SI; Gribabis DA; Dimopoulou MN; Angelopoulou MK; Pangalis GA
Eur J Haematol; 2004 Apr; 72(4):252-8. PubMed ID: 15089762
[TBL] [Abstract][Full Text] [Related]
40. [Diagnostic-therapeutic management of parathyroid carcinoma].
Sillero Sánchez A; Atienza Iglesias MA
An Med Interna; 2002 Dec; 19(12):644-8. PubMed ID: 12593036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
